Clinical implications of airway obstruction with normal or low FEV1 in childhood and adolescence

被引:3
|
作者
Koefoed, Hans Jacob Lohne [1 ,2 ,3 ,4 ]
Wang, Gang [2 ,5 ,6 ,7 ]
Gehring, Ulrike [8 ]
Ekstrom, Sandra [2 ,6 ,9 ]
Kull, Inger [2 ,10 ]
Vermeulen, Roel [8 ]
Boer, Jolanda M. A. [11 ]
Bergstrom, Anna [6 ,9 ]
Koppelman, Gerard H. [3 ,4 ]
Melen, Erik [2 ,10 ]
Vonk, Judith M. [4 ,12 ]
Hallberg, Jenny [2 ,10 ]
机构
[1] Karolinska Inst, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden
[3] Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands
[4] Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands
[5] Sichuan Univ, West China Hosp, Dept Integrated Tradit Chinese & Western Med, Chengdu, Sichuan, Peoples R China
[6] Inst Environm Med, Karolinska Inst, Stockholm, Sweden
[7] Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu, Peoples R China
[8] Univ Utrecht, Univ Med Ctr Utrecht, Utrecht, Netherlands
[9] Ctr Occupat & Environm Med, Stockholm, Region Stockhol, Sweden
[10] Sachs Childrens Hosp, Pediat, Stockholm, Sweden
[11] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands
[12] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
关键词
Asthma; Asthma Epidemiology; Lung Physiology; Paediatric asthma; Clinical Epidemiology; Asthma Guidelines; REDUCED LUNG-FUNCTION; WHEEZING PHENOTYPES; BIRTH COHORT; ASTHMA; CHILDREN; GROWTH; SPIROMETRY; ALLERGY; ASSOCIATIONS; PREVENTION;
D O I
10.1136/thorax-2023-220952
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Airway obstruction is defined by spirometry as a low forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) ratio. This impaired ratio may originate from a low FEV1 (classic) or a normal FEV1 in combination with a large FVC (dysanaptic). The clinical implications of dysanaptic obstruction during childhood and adolescence in the general population remain unclear. Aims To investigate the association between airway obstruction with a low or normal FEV1 in childhood and adolescence, and asthma, wheezing and bronchial hyperresponsiveness (BHR). Methods In the BAMSE (Barn/Child, Allergy, Milieu, Stockholm, Epidemiology; Sweden) and PIAMA (Prevention and Incidence of Asthma and Mite Allergy; the Netherlands) birth cohorts, obstruction (FEV1:FVC ratio less than the lower limit of normal, LLN) at ages 8, 12 (PIAMA only) or 16 years was classified as classic (FEV1 <LLN) or dysanaptic (FEV1 >= LLN) obstruction. Cross-sectional and longitudinal associations between these two types of obstruction and respiratory health outcomes were estimated by cohort-adjusted logistic regression on pooled data. Results The prevalence of classic obstruction at ages 8, 12 and 16 in the two cohorts was 1.5%, 1.1% and 1.5%, respectively. Dysanaptic obstruction was slightly more prevalent: 3.9%, 2.5% and 4.6%, respectively. Obstruction, regardless of FEV1, was consistently associated with higher odds of asthma (dysanaptic obstruction: OR 2.29, 95% CI 1.40 to 3.74), wheezing, asthma medication use and BHR compared with the normal lung function group. Approximately one-third of the subjects with dysanaptic obstruction in childhood remained dysanaptic during adolescence. Clinical implications Children and adolescents with airway obstruction had, regardless of their FEV1 level, a higher prevalence of asthma and wheezing. Follow-up and treatment at these ages should be guided by the presence of airway obstruction.
引用
收藏
页码:573 / 580
页数:8
相关论文
共 50 条
  • [41] FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: Do prediction equations need revision?
    Roche, Nicolas
    Dalmay, Francois
    Perez, Thierry
    Kuntz, Claude
    Vergnenegre, Alain
    Neukirch, Francoise
    Giodanella, Jean-Pierre
    Huchon, Gerard
    RESPIRATORY MEDICINE, 2008, 102 (11) : 1568 - 1574
  • [42] The Significance Of Low Fef25-75 As An Indicator Of Obstructive Airway Disease In The Presence Of Normal Fev1/FVC Ratio
    Ghazarian, Z.
    Ponce, F. D.
    Naranjo, M. B.
    Sekhon, R.
    Hanna, M.
    Pandya, T.
    Labban, M.
    Ismail, M.
    Khan, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [43] Evaluating the FEV1/FVC ratio in the lower range of normality as a marker of worse clinical outcomes in asthmatic subjects without airway obstruction
    Mingotti, Cintia
    Sarinho, Jose
    Stanigher, Katia
    Silva, Jucara
    Roquette, Eduardo
    Marchi, Evaldo
    Ponte, Eduardo Vieira
    RESPIRATORY MEDICINE, 2020, 162
  • [44] AIRWAY HYPERRESPONSIVENESS IS ASSOCIATED WITH GREATER LONGITUDINAL CHANGE OF FEV1
    RIJCKEN, B
    SCHOUTEN, JP
    XU, XP
    WEISS, ST
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A371 - A371
  • [45] Exercise capacity and gas exchange in smokers with discordant GOLD vs FEV1/FVC lower limit of normal (LLN) airway obstruction diagnosis
    Ciacco, Claudio
    Guglielmo, Marco
    Giannoccaro, Fabiana
    Torchio, Roberto
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [46] How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1
    Barisione, G.
    Crimi, E.
    Bartolini, S.
    Saporiti, R.
    Copello, F.
    Pellegrino, R.
    Brusasco, V.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (06) : 1396 - 1402
  • [47] COMPARISON OF SPECIFIC AIRWAY RESISTANCE AND FEV1 FOR BRONCHODILATOR RESPONSE
    Zhang, Y.
    Patterson, J.
    Martin, A.
    Schultz, C.
    Borgas, T.
    RESPIROLOGY, 2016, 21 : 12 - 12
  • [48] Bronchodilators in school children with asthma and normal FEV1
    Kamenov, Svetlana
    Cekic, Snezana
    Kamenov, Aleksandar
    Kamenov, Borislav
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [49] Bronchodilators in school children with asthma and normal FEV1
    Kamenov, Svetlana
    Kamenov, Aleksandar
    Kamenov, Borislav
    Cekic, Snezana
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [50] BEYOND FEV1: LATEST BIOMARKERS FOR ADULT AIRWAY DISEASE
    Rowe, S. M.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2013, 26 (02) : A2 - A2